Platelet glycoprotein IIb/IIIa antagonists: pharmacology and clinical developments

Anesthesiology. 2002 May;96(5):1237-49. doi: 10.1097/00000542-200205000-00029.

Authors

Peter C A Kam¹, Mark K Egan

Affiliation

¹ Department of Anaesthesia and Pain Management, University of Sydney at the Royal North Shore Hospital, St Leonards, New South Wales, Australia. pkam@med.usyd.edu.au

PMID: 11981166
DOI: 10.1097/00000542-200205000-00029

No abstract available

Publication types

Review

MeSH terms

Animals
Blood Platelets / physiology*
Clinical Trials as Topic
Coronary Artery Bypass / adverse effects
Humans
Intraoperative Complications / blood
Intraoperative Complications / prevention & control
Platelet Aggregation Inhibitors / classification
Platelet Aggregation Inhibitors / pharmacokinetics
Platelet Aggregation Inhibitors / pharmacology*
Platelet Aggregation Inhibitors / therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Thrombosis / blood
Thrombosis / prevention & control

Substances

Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex